Clinical study on inhalation of budesonid with nebulizer in the treatment of children with asthma

LI Zhen,CHEN Yu-zhi,CHEN Ai-huan,CHEN Kun-hua,HUANG Ying,LI Yun-zhu,SHENG Jin-yun,YU Shan-chang,HONG Jian-guo,LI Zhi-ying,YUAN Yi

DOI: https://doi.org/10.3969/j.issn.1000-3606.2008.03.018

2008-01-01

Abstract:Objectives To evaluate the clinical effects of inhalation of budesonid with nebulizer via jet(NE-C28) on children younger than 5 years old with asthma.Methods Budesonid were given with nebulizer for 6 weeks in 61 children(aged 5 ～62 months)with recurrent wheeze.Symptomatic score during daytime and night were recorded by the patients each day.Patients were followed-up and the scores were assessed every week after treatment.The differences on symptomatic score every week,between first week and 2,3,4,5,6 week after treatment were analyzed.Results The differences in the symptom score were significant between the first week and every week after treatment(P < 0.05=,while the difference in every week after treatment were not significant.The clinical effective rates increased significantly after 2 weeks'treatment(56.8%),and reached to 68.2% in week 6.There were no significant side-effects reported by the patients during the period of treatment.Conclusions Inhalation of budesonid with nebulizer is effective for alleviating clinical symptom of asthma and it is really a safe,well-compliance therapeutic approach for children younger than 5 years old with asthma.